AI-powered global mental health benefits for enterprise employers
Lyra Health provides AI-powered mental health benefits to enterprise employers, combining evidence-based therapy, medication management, and coaching across a network of curated providers. Founded in 2015 by David Ebersman (former Facebook CFO) and Dena Bravata, the company became a unicorn in 2020 and reached a $5.58B valuation in early 2022 following a $235M Dragoneer-led round. Lyra has since raised an additional $200M led by Coatue, bringing total funding to $915M. The platform supports 17M+ employees across 2,500+ organizations including Amgen, eBay, Meta, Morgan Stanley, Starbucks, Uber, and Zoom.
Healthcare📍 Burlingame, CAFounded 2015
Current Valuation
$5.6B
as of 2022-Q1
UNICORN
QL Price
$5.6B
0% vs last round
QuantLogix's current estimate for Lyra Health, published 2026-08-29 — in line with the last disclosed round of $5.6B (2022-Q1).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$5.6B
2022-Q1
weight 0.05
How this price has held up
No round has priced for Lyra Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-08-29 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Lyra Health, 2026-08-29 (7abba07464846126).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Lyra Health going public?
No. Lyra Health is private and has not filed to go public. There is no S-1 on file.
What is Lyra Health's valuation in 2026?
Lyra Health is valued at $5.6B as of 2022-Q1, set by its Funding round ($200M, Jan 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Lyra Health filed an S-1?
No public S-1 is on file for Lyra Health.
Who are Lyra Health's investors?
Lyra Health's investors include Coatue, Dragoneer, Addition, Greylock, IVP, Salesforce Ventures and 1 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
David Ebersman
Founded
2015
HQ
Burlingame, CA
Employees
~2700
Total Raised
$915M
Growth
17M+ covered lives across 2,500+ employers; global expansion
Last Round
Funding round — $200M (Jan 2024) · Lead: Coatue
IPO Status
private
Fundraising Status
Funding round · $200M · 2y 7mo ago
privateTotal raised $915M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Funding round
$200M
Jan 2024
Coatue
—
Talent Signal
Hiring trend
▼ Hiring downtrend
8% of roles posted in last 30d
Open roles
534
via lever
Product-build share
44%
engineering, research, product, design
Trajectory
tightening
balanced build + GTM — 44% builders vs 56% go-to-market/G&A — scaling both sides.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Clinical Care Navigator - After HoursClinical Care Navigator - After Hours - Bilingual Spanish SpeakingClinical ConsultantClinical Product Manager (PhD/PsyD)Clinical Product Specialist, AI DevelopmentEngineering Manager
Counted from Lyra Health's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Lyra Global (international mental health benefits)
Competitors
Spring Health · Modern Health · Headspace Health · Calm Health
HealthcareMental HealthEnterprise BenefitsUnicorn
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.